Current Multiple Sclerosis Clinical Trials at Shepherd Center
Volunteer for Multiple Sclerosis Research Studies
MS clinical trials help to determine if treatments and other interventions are safe and effective. Participation from people with MS helps researchers develop new and improved interventions and therapies.
Submit Your Request to Participate in an MS Clinical Trial
People with MS may apply to be participants in multiple sclerosis clinical studies at Shepherd Center. Ongoing research studies may or may not be actively recruiting participants. To be considered for current and future research studies, complete and submit our MS Research Intake Form.
Request to Participate in a Clinical Trial
MS Trials Seeking Participants
Do you qualify to be an MS trial research participant? See the list below to learn more about the current multiple sclerosis clinical trials and studies at Shepherd Center.
+The Calliper Study: Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients with Progressive Multiple Sclerosis
Purpose: This study is being done for patients who have a diagnosis of Primary or Secondary Progressive Multiple Sclerosis. The purpose of this study is to assess the effects of an investigational product called IMU-838, a tablet containing vidofludimus calcium, on disease activity and to assess safety.
To participate in this MS trial, you must:
- Be between the ages of 18 and 65
- Be stable with no relapses for the past 24 months
- Have a diagnosis of primary or secondary progressive multiple sclerosis
To learn more about MS trial research, contact Ashley Howard, RN, BSN, at 404-367-1279 or email firstname.lastname@example.org.
+STEP for MS: a study to compare the impacts of an exercise program for people with MS when delivered at home compared to in a gym facility (738)
Purpose: The purpose of this study is to determine whether an evidence-based exercise program delivered virtually by telephone and computer (“telerehab”) produces the same benefits for improving walking and mobility, participation, and quality of life in people with multiple sclerosis when compared to delivery of the program in an exercise facility.
Recruitment for this study is now closed.
Contact: Erica Sutton, at 404-367-1305 or email email@example.com